Philips and Masimo’s patient monitoring collaboration was a somewhat unlikely one when it began in 2016: Their agreement was announced in the same release that heralded the end of a years-long legal ...

On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.

The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.

IRVINE, Calif. & ANDOVER, Mass.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) and Royal Philips (NYSE: PHG, AEX: PHIA) today announced an expansion of their partnership to augment patient monitoring ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI) today announced that the two companies have renewed their multi-year ...

Masimo, a lead developer of patient sensing and monitoring technology, has expanded its two decade long partnership with Royal Philips. The two have also renewed their partnership for several more ...

Irvine, California-based Masimo Technologies, which makes non-invasive patient monitoring devices and sensors, has received FDA 510(k) clearance for its forehead sensor. The adhesive TFA-1 Forehead ...

Medtech companies Phillips and Masimo partnered to integrate Philips’ patient monitoring ecosystem into the Masimo W1 tracking watch. The partnership will use Masimo’s secure health data cloud and ...

Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the integration of its Nellcor™ OxiMax™ oximetry system into Philips IntelliVue and M-Series patient monitors.

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking and release of RD rainbow Lite SET™ sensors, which enable the monitoring of Masimo Oxygen Reserve Index™ ...